Market adjustments in NASDAQ are often immediate and extreme. Should SMCI have gone down? Yes. But 45%? I think not. I'm in at 7 and I am willing to wait. My logic is similiar, Mitch. A 1-time R&D is NOT permanent bleeding. They have a good product, great customers, have been profitable, and they have just taken a BIG hit. I think that for the short-term, the market is finding its bottom. (Is it around 7?) After that happens, maybe the market will realize that SMCI is undervalued. This happens so often on the NASDAQ with basically good companies, such as EFII, CYMI, ADPT, CTXS, SECX, ENPT, to name a few. But then, NASDAQ's beta is almost double the NYSE's. Good luck bottom fishing We'll see.... dwight
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat